A Phase 2 Efficacy and Safety Study of Niraparib in Men with Metastatic Castration-resistant Prostate Cancer and DNA-Repair Anomalies

Administered By

Awarded By

Contributors

Start/End

  • October 4, 2017 - October 31, 2020